Health● Elevated17h ago · Nov 9, 2026, 5:19 PM
US drug watchdog orders new safety warnings for weight-loss drugs over potential risk of vision loss
GlobeAlert Desk · curated from EuroNews [en] · North America
The US Food and Drug Administration (FDA) is requiring manufacturers of GLP-1 medicines to update their safety labels to warn of a potential increased risk of a rare but serious eye condition that can cause permanent vision loss.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
2 Elevated
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Health
Not flagged as developing.
North America theater · last 7 days
rising · 30 in the last 24h659
events logged
95
risk index / 100
Attacks & Assaults 289Shootings 137Robberies & Theft 126Rocket Launches 40Earthquakes 24
- Cyber activity (100 reports)Cyber Threats · · 3m ago
- Protest activity (143 reports)Protests · · 5m ago
- Conflict activity (158 reports)Conflict Events · · 6m ago
More in Health
Health56m agoPolice launch investigation after 25 California Half Marathon runners rushed to hospital with mystery illnessThe Independent WorldHealth1h agoHow word of mouth is helping an Amish community's fight against measlesNPR NewsHealth3h agoFDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, ZepboundCNBCHealth4h agoRestaurants’ operation suspension was necessary when violations posed extremely serious food safety hazard: Telangana SAFE chiefThe Hindu